Biocon is one of India’s leading biopharmaceutical companies, known for its strong presence in the global healthcare market. Investors are keen to know the future potential of Biocon’s stock, considering its focus on biosimilars, research, and global expansion. Biocon Share Price on 19 March 2025 is 342.25 INR. This article will provide more details on Biocon Share Price Target 2025, 2026 to 2030.
Biocon Company Info
- CEO: Siddharth Mittal (1 Dec 2019–)
- Founded: 1978
- Founder: Kiran Mazumdar-Shaw
- Headquarters: Bengaluru
- Number of employees: 16,315 (2024)
- Revenue: 11,550 crores INR (US$1.4 billion, 2023)
- Subsidiaries: Biocon Biologics Limited
Biocon Share Price Chart
Biocon Share Price Details
- Today Open: 338.70
- Today High: 343.20
- Today Low: 334.05
- Mkt cap: 41.02KCr
- P/E ratio: 50.94
- Div yield: 0.15%
- 52-wk high: 404.70
- 52-wk low: 244.55
Biocon Shareholding Pattern
- Promoters: 60.64%
- Foreign Institutions: 5.66%
- Mutual Funds: 8.58%
- Retails and others: 18.34%
- Domestic Institutions: 6.78%
Biocon Share Price Target Tomorrow 2025, 2026 To 2030
- 2025 – ₹410
- 2026 – ₹510
- 2027 – ₹610
- 2028 – ₹710
- 2029 – ₹810
- 2030 – ₹910
Biocon Share Price Target 2025
Biocon share price target 2025 Expected target could be ₹410. Here are 5 Key Factors Affecting Growth for Biocon Share Price Target 2025:
-
Expansion in Biosimilars Market – Biocon is a leading player in the biosimilars industry, and its expanding global footprint in this segment can drive strong revenue growth.
-
Regulatory Approvals & New Drug Launches – Success in obtaining regulatory approvals for new drugs and biosimilars, especially in key markets like the US and Europe, will boost investor confidence.
-
Strategic Partnerships & Collaborations – Collaborations with global pharmaceutical companies for research, manufacturing, and distribution will enhance Biocon’s market presence and revenue streams.
-
Increased Healthcare Spending – The growing demand for affordable biologic drugs and increased healthcare spending in emerging markets will create new opportunities for Biocon’s products.
-
Research & Development (R&D) Strength – Continuous investments in R&D for innovative therapies and advanced biologics will play a crucial role in Biocon’s long-term success and market valuation.
Biocon Share Price Target 2030
Biocon share price target 2030 Expected target could be ₹910. Here are 5 Key Factors Affecting Growth for Biocon Share Price Target 2030:
-
Global Expansion of Biosimilars – Biocon’s focus on biosimilars, especially in regulated markets like the US and Europe, will be a key driver for long-term revenue growth.
-
Pipeline of Innovative Biologic Drugs – The success of Biocon’s research and development (R&D) in creating new biologics and specialty medicines will significantly impact its market valuation.
-
Regulatory Landscape & Approvals – Smooth regulatory approvals in key markets will help Biocon maintain a steady flow of product launches and market expansion.
-
Increased Demand for Affordable Healthcare – With rising healthcare costs, demand for cost-effective biosimilars and generic drugs is expected to grow, creating new opportunities for Biocon.
-
Strategic Mergers & Acquisitions – Potential collaborations, acquisitions, and joint ventures with global pharmaceutical firms can strengthen Biocon’s market position and accelerate growth.
Financials Statement Of Biocon
| (INR) | 2024 | Y/Y change |
| Revenue | 147.56B | 32.05% |
| Operating expense | 73.90B | 36.92% |
| Net income | 10.23B | 120.99% |
| Net profit margin | 6.93 | 67.39% |
| Earnings per share | 8.62 | 306.13% |
| EBITDA | 33.06B | 24.43% |
| Effective tax rate | 14.91% | — |
Read Also:- KPIT Share Price Target Tomorrow 2025, 2026 To 2030